In fact, the AR-binding profile in this cell line is more similar to the breast cancer ER-cistrome than AR-binding events in prostate cancer, indicating that FOXA1 directs AR binding to ER consensus sites. The gene discussed is FOXA1; the disease is prostate cancer.